Y. Demir Et Al. , "Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif," ARCHIV DER PHARMAZIE , vol.356, 2023
Demir, Y. Et Al. 2023. Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif. ARCHIV DER PHARMAZIE , vol.356 .
Demir, Y., TÜRKEŞ, C., ÇAVUŞ, M. S., Erdogan, M., MUĞLU, H., YAKAN, H., ... BEYDEMİR, Ş.(2023). Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif. ARCHIV DER PHARMAZIE , vol.356.
Demir, Yeliz Et Al. "Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif," ARCHIV DER PHARMAZIE , vol.356, 2023
Demir, Yeliz Et Al. "Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif." ARCHIV DER PHARMAZIE , vol.356, 2023
Demir, Y. Et Al. (2023) . "Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif." ARCHIV DER PHARMAZIE , vol.356.
@article{article, author={Yeliz Demir Et Al. }, title={Enzyme inhibition, molecular docking, and density functional theory studies of new thiosemicarbazones incorporating the 4-hydroxy-3,5-dimethoxy benzaldehyde motif}, journal={ARCHIV DER PHARMAZIE}, year=2023}